RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
GP concern over new Ozempic copycat Telehealth start-up Eucalyptus will soon start selling compounded semaglutide, amid a worldwide shortage of the viral drug.
Plea for psychedelic rules reform A new coalition of healthcare professionals wants a review of ‘overly restrictive’ prescribing guidelines, but a GP expert says changes must be done ‘slowly and carefully’.
Turmeric supplement warning after fatality: TGA The health watchdog is calling on GPs to be aware of supplements containing the common spice after 18 consumers reported liver injuries.
TGA flags focus on illegal vapes Unlawful nicotine vaping products and medicinal cannabis advertising are priority areas for the medicine regulator for the next year.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
Pharmacy green light for insulin swap due to shortage Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.
New advice for ‘unprecedented’ antibiotics shortage With ongoing supply issues, Therapeutic Guidelines has released a guide for prescribers on alternatives in the absence of first-line therapies.
Telehealth provider defies TGA semaglutide request Eucalyptus is reportedly offering patients access to the type 2 diabetes-indicated drug for weight loss purposes, despite ongoing supply issues.
Psychedelic prescribing to begin for PTSD and depression Experts are split on whether Australia is prepared for psychedelic-assisted therapy, but GPs need to be ready to answer questions and refer patients.